Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease
- 1 March 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 393 (1-3) , 165-170
- https://doi.org/10.1016/s0014-2999(00)00093-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's DiseaseJournal of Neurochemistry, 1999
- Cholinesterase Inhibitors in the Treatment of Alzheimer??s DiseaseDrug Safety, 1998
- Choline is a Selective Agonist of α7 Nicotinic Acetylcholine Receptors in the Rat Brain NeuronsEuropean Journal of Neuroscience, 1997
- New approach to drug therapy in Alzheimer's dementia Alfred Maelicke and Edson X. AlbuquerqueDrug Discovery Today, 1996
- Nicotinic Receptor Function in SchizophreniaSchizophrenia Bulletin, 1996
- Kinetic Analysis of Regional (S)(-)11C-Nicotine Binding in Normal and Alzheimer Brains In Vivo Assessment Using Positron Emission TomographyAlzheimer Disease & Associated Disorders, 1995
- CNS Nicotinic ReceptorsCNS Drugs, 1994
- A Novel Agonist Binding Site on Nicotinic Acetylcholine ReceptorsJournal of Receptor Research, 1993
- Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's diseaseNeurobiology of Aging, 1991
- Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brainsNeuroscience Letters, 1986